Skip to content

GILD

Gilead Sciences, Inc.

Cash flow statement

Cash flow statement
Line, in USDLast 12 months2025202420232022202120202019201820172016201520142013201220112010200920082007
Operating cash flow14.5B10.0B10.8B8.0B9.1B11.4B8.2B9.1B8.4B11.9B17.0B21.3B12.8B3.1B3.2B3.6B2.8B3.1B2.1B1.7B
699M563M523M585M728M579M650M825M924M————134M——————
Free cash flow13.8B9.5B10.3B7.4B8.3B10.8B7.5B8.3B7.5B————3.0B——————
Depreciation and amortization2.81B2.76B2.77B2.69B2.10B2.05B1.48B1.40B1.43B1.29B1.16B1.10B1.05B0.35B0.28B0.30B0.27B0.21B0.16B0.10B
Stock-based compensation913M894M835M766M637M635M643M636M845M638M380M382M360M252M209M192M200M181M153M185M
Buybacks1.4B1.9B1.2B1.0B1.4B546M1.6B1.7B2.9B954M11.0B10.0B5.3B582M667M2.4B4.0B998M2.0B488M
Dividends paid4.10B4.00B3.92B3.81B3.71B3.61B3.45B3.22B2.97B2.73B2.46B1.87B00——————
Dividends per share3.253.163.083.002.922.842.722.522.282.081.841.290.000.00——————
Free cash flow margin44.5%32.1%35.8%27.4%30.6%39.6%30.5%37.1%33.8%————26.5%——————